_id
690f351bccc777a4e85d16bf
Ticker
BHST
Name
BioHarvest Sciences Inc. Common Stock
Exchange
OTCQB
Address
1140-625 Howe Street, Vancouver, BC, Canada, V6C 2T6
Country
USA
Sector
Consumer Defensive
Industry
Packaged Foods
Currency
USD
Website
https://www.bioharvest.com
Description
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
Last Close
4.94
Volume
17185
Current Price
4.94
Change
0.06
Last Updated
2026-01-20T16:32:25.997Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
110614192
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
9067000
Cost Of Revenue
3497000
Gross Profit
5570000
Operating Expenses
9987000
Operating Income
-920000
Interest Expense
1530000
Pretax Income
-2450000
Net Income
-2513000
Eps
-0.12810722467652033
Dividends Per Share
-
Shares Outstanding
22666842
Income Tax Expense
-
EBITDA
-
Operating Margin
-10.146685783610897
Total Other Income Expense Net
-
Cash
10966000
Short Term Investments
-
Receivables
1377000
Inventories
4434000
Total Current Assets
17839000
Property Plant Equipment
16944000
Total Assets
35188000
Payables
3485000
Short Term Debt
-
Long Term Debt
2343000
Total Liabilities
27453000
Equity
7735000
Bs_currency_symbol
USD
Depreciation
385000
Change In Working Capital
-768000
Cash From Operations
-2091000
Capital Expenditures
425000
Cash From Investing
-
Cash From Financing
9736000
Net Change In Cash
7220000
Cf_currency_symbol
USD
PE
-
PB
12.528108235294118
ROE
-32.48868778280543
ROA
-7.141639195180175
FCF
-2516000
Fcf Percent
-0.27748979816918495
Piotroski FScore
1
Health Score
9
Deep Value Investing Score
1.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
9067000
Quarters > 0 > income Statement > cost Of Revenue
3497000
Quarters > 0 > income Statement > gross Profit
5570000
Quarters > 0 > income Statement > operating Expenses
9987000
Quarters > 0 > income Statement > operating Income
-920000
Quarters > 0 > income Statement > interest Expense
1530000
Quarters > 0 > income Statement > pretax Income
-2450000
Quarters > 0 > income Statement > net Income
-2513000
Quarters > 0 > income Statement > eps
-0.12810722467652033
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19616380
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-10.146685783610897
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10966000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1377000
Quarters > 0 > balance Sheet > inventories
4434000
Quarters > 0 > balance Sheet > total Current Assets
17839000
Quarters > 0 > balance Sheet > property Plant Equipment
16944000
Quarters > 0 > balance Sheet > total Assets
35188000
Quarters > 0 > balance Sheet > payables
3485000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
2343000
Quarters > 0 > balance Sheet > total Liabilities
27453000
Quarters > 0 > balance Sheet > equity
7735000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2513000
Quarters > 0 > cash Flow > depreciation
385000
Quarters > 0 > cash Flow > change In Working Capital
-768000
Quarters > 0 > cash Flow > cash From Operations
-2091000
Quarters > 0 > cash Flow > capital Expenditures
425000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
9736000
Quarters > 0 > cash Flow > net Change In Cash
7220000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.12810722467652033
Quarters > 0 > ratios > PB
12.528108235294118
Quarters > 0 > ratios > ROE
-32.48868778280543
Quarters > 0 > ratios > ROA
-7.141639195180175
Quarters > 0 > ratios > FCF
-2516000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.27748979816918495
Quarters > 0 > health Score
9
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8515000
Quarters > 1 > income Statement > cost Of Revenue
3429000
Quarters > 1 > income Statement > gross Profit
5086000
Quarters > 1 > income Statement > operating Expenses
10330000
Quarters > 1 > income Statement > operating Income
-1815000
Quarters > 1 > income Statement > interest Expense
2226000
Quarters > 1 > income Statement > pretax Income
-4041000
Quarters > 1 > income Statement > net Income
-4080000
Quarters > 1 > income Statement > eps
-0.23538330267004282
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
17333430
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-21.31532589547857
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
3727000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1614000
Quarters > 1 > balance Sheet > inventories
4127000
Quarters > 1 > balance Sheet > total Current Assets
10326000
Quarters > 1 > balance Sheet > property Plant Equipment
17075000
Quarters > 1 > balance Sheet > total Assets
27798000
Quarters > 1 > balance Sheet > payables
3421000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
5262000
Quarters > 1 > balance Sheet > total Liabilities
32021000
Quarters > 1 > balance Sheet > equity
-4223000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4080000
Quarters > 1 > cash Flow > depreciation
407000
Quarters > 1 > cash Flow > change In Working Capital
343000
Quarters > 1 > cash Flow > cash From Operations
-1456000
Quarters > 1 > cash Flow > capital Expenditures
592000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2386000
Quarters > 1 > cash Flow > net Change In Cash
338000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.23538330267004282
Quarters > 1 > ratios > PB
-20.276377977740946
Quarters > 1 > ratios > ROE
96.61378167179731
Quarters > 1 > ratios > ROA
-14.677314914742068
Quarters > 1 > ratios > FCF
-2048000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.24051673517322372
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7860000
Quarters > 2 > income Statement > cost Of Revenue
3265000
Quarters > 2 > income Statement > gross Profit
4595000
Quarters > 2 > income Statement > operating Expenses
9579000
Quarters > 2 > income Statement > operating Income
-1719000
Quarters > 2 > income Statement > interest Expense
581000
Quarters > 2 > income Statement > pretax Income
-2300000
Quarters > 2 > income Statement > net Income
-2338000
Quarters > 2 > income Statement > eps
-0.1349283425467038
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
17327716
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-21.870229007633586
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3401000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1476000
Quarters > 2 > balance Sheet > inventories
4012000
Quarters > 2 > balance Sheet > total Current Assets
9643000
Quarters > 2 > balance Sheet > property Plant Equipment
16587000
Quarters > 2 > balance Sheet > total Assets
26591000
Quarters > 2 > balance Sheet > payables
3734000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
27467000
Quarters > 2 > balance Sheet > equity
-876000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2338000
Quarters > 2 > cash Flow > depreciation
399000
Quarters > 2 > cash Flow > change In Working Capital
11000
Quarters > 2 > cash Flow > cash From Operations
-1427000
Quarters > 2 > cash Flow > capital Expenditures
684000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3122000
Quarters > 2 > cash Flow > net Change In Cash
1015000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.1349283425467038
Quarters > 2 > ratios > PB
-97.7156587214612
Quarters > 2 > ratios > ROE
266.89497716894977
Quarters > 2 > ratios > ROA
-8.792448572825393
Quarters > 2 > ratios > FCF
-2111000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.2685750636132316
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7278000
Quarters > 3 > income Statement > cost Of Revenue
3155000
Quarters > 3 > income Statement > gross Profit
4123000
Quarters > 3 > income Statement > operating Expenses
8965000
Quarters > 3 > income Statement > operating Income
-1687000
Quarters > 3 > income Statement > interest Expense
83000
Quarters > 3 > income Statement > pretax Income
-2948000
Quarters > 3 > income Statement > net Income
-2956000
Quarters > 3 > income Statement > eps
-0.17059374703509683
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
17327716
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-23.179444902445727
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2390000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1116000
Quarters > 3 > balance Sheet > inventories
3655000
Quarters > 3 > balance Sheet > total Current Assets
7856000
Quarters > 3 > balance Sheet > property Plant Equipment
16774000
Quarters > 3 > balance Sheet > total Assets
25001000
Quarters > 3 > balance Sheet > payables
3525000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
23671000
Quarters > 3 > balance Sheet > equity
1330000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-22870000
Quarters > 3 > cash Flow > depreciation
341000
Quarters > 3 > cash Flow > change In Working Capital
-379000
Quarters > 3 > cash Flow > cash From Operations
-2389000
Quarters > 3 > cash Flow > capital Expenditures
393000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2454000
Quarters > 3 > cash Flow > net Change In Cash
-335000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.17059374703509683
Quarters > 3 > ratios > PB
64.360088
Quarters > 3 > ratios > ROE
-222.25563909774436
Quarters > 3 > ratios > ROA
-11.823527058917643
Quarters > 3 > ratios > FCF
-2782000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.38224787029403684
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
25188000
Annuals > 0 > income Statement > cost Of Revenue
11246000
Annuals > 0 > income Statement > gross Profit
13942000
Annuals > 0 > income Statement > operating Expenses
32177000
Annuals > 0 > income Statement > operating Income
-6989000
Annuals > 0 > income Statement > interest Expense
4738000
Annuals > 0 > income Statement > pretax Income
-12905000
Annuals > 0 > income Statement > net Income
-12913000
Annuals > 0 > income Statement > eps
-0.7452222785738178
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
17327716
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-27.747340003176113
Annuals > 0 > income Statement > total Other Income Expense Net
-483000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2390000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1116000
Annuals > 0 > balance Sheet > inventories
3655000
Annuals > 0 > balance Sheet > total Current Assets
7856000
Annuals > 0 > balance Sheet > property Plant Equipment
16774000
Annuals > 0 > balance Sheet > total Assets
25001000
Annuals > 0 > balance Sheet > payables
3525000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
23671000
Annuals > 0 > balance Sheet > equity
1330000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-12913000
Annuals > 0 > cash Flow > depreciation
1251000
Annuals > 0 > cash Flow > change In Working Capital
-555000
Annuals > 0 > cash Flow > cash From Operations
-6684000
Annuals > 0 > cash Flow > capital Expenditures
2835000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
6780000
Annuals > 0 > cash Flow > net Change In Cash
-2931000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.7452222785738178
Annuals > 0 > ratios > PB
64.360088
Annuals > 0 > ratios > ROE
-970.9022556390977
Annuals > 0 > ratios > ROA
-51.649934002639895
Annuals > 0 > ratios > FCF
-9519000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.37791805621724633
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
12672000
Annuals > 1 > income Statement > cost Of Revenue
7039000
Annuals > 1 > income Statement > gross Profit
5633000
Annuals > 1 > income Statement > operating Expenses
22638000
Annuals > 1 > income Statement > operating Income
-9966000
Annuals > 1 > income Statement > interest Expense
1962000
Annuals > 1 > income Statement > pretax Income
-12564000
Annuals > 1 > income Statement > net Income
-12564000
Annuals > 1 > income Statement > eps
-0.9186356695613975
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
13676804
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-78.64583333333334
Annuals > 1 > income Statement > total Other Income Expense Net
-500000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
5355000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
808000
Annuals > 1 > balance Sheet > inventories
2466000
Annuals > 1 > balance Sheet > total Current Assets
9052000
Annuals > 1 > balance Sheet > property Plant Equipment
5771000
Annuals > 1 > balance Sheet > total Assets
15002000
Annuals > 1 > balance Sheet > payables
1778000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
29855000
Annuals > 1 > balance Sheet > equity
-14853000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-12564000
Annuals > 1 > cash Flow > depreciation
840000
Annuals > 1 > cash Flow > change In Working Capital
755000
Annuals > 1 > cash Flow > cash From Operations
-8522000
Annuals > 1 > cash Flow > capital Expenditures
1474000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
13556000
Annuals > 1 > cash Flow > net Change In Cash
3560000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.9186356695613975
Annuals > 1 > ratios > PB
-4.548805746987141
Annuals > 1 > ratios > ROE
84.58897192486367
Annuals > 1 > ratios > ROA
-83.74883348886814
Annuals > 1 > ratios > FCF
-9996000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.7888257575757576
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
5498000
Annuals > 2 > income Statement > cost Of Revenue
4279000
Annuals > 2 > income Statement > gross Profit
1219000
Annuals > 2 > income Statement > operating Expenses
16110000
Annuals > 2 > income Statement > operating Income
-10612000
Annuals > 2 > income Statement > interest Expense
1399000
Annuals > 2 > income Statement > pretax Income
-11236000
Annuals > 2 > income Statement > net Income
-11236000
Annuals > 2 > income Statement > eps
-0.8535839205331298
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
13163322
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-193.01564205165516
Annuals > 2 > income Statement > total Other Income Expense Net
861000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1736000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
545000
Annuals > 2 > balance Sheet > inventories
1378000
Annuals > 2 > balance Sheet > total Current Assets
4322000
Annuals > 2 > balance Sheet > property Plant Equipment
4908000
Annuals > 2 > balance Sheet > total Assets
9393000
Annuals > 2 > balance Sheet > payables
1067000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
15322000
Annuals > 2 > balance Sheet > equity
-5929000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11236000
Annuals > 2 > cash Flow > depreciation
712000
Annuals > 2 > cash Flow > change In Working Capital
-308000
Annuals > 2 > cash Flow > cash From Operations
-9241000
Annuals > 2 > cash Flow > capital Expenditures
1256000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
8138000
Annuals > 2 > cash Flow > net Change In Cash
-2359000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.8535839205331298
Annuals > 2 > ratios > PB
-10.967584867599934
Annuals > 2 > ratios > ROE
189.50919210659472
Annuals > 2 > ratios > ROA
-119.62099435750027
Annuals > 2 > ratios > FCF
-10497000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.9092397235358312
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2102000
Annuals > 3 > income Statement > cost Of Revenue
1432000
Annuals > 3 > income Statement > gross Profit
670000
Annuals > 3 > income Statement > operating Expenses
10593000
Annuals > 3 > income Statement > operating Income
-8491000
Annuals > 3 > income Statement > interest Expense
805000
Annuals > 3 > income Statement > pretax Income
-9827000
Annuals > 3 > income Statement > net Income
-9827000
Annuals > 3 > income Statement > eps
-0.7582058012966886
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
12960861
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-403.9486203615605
Annuals > 3 > income Statement > total Other Income Expense Net
-484000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4117000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
386000
Annuals > 3 > balance Sheet > inventories
928000
Annuals > 3 > balance Sheet > total Current Assets
5665000
Annuals > 3 > balance Sheet > property Plant Equipment
4364000
Annuals > 3 > balance Sheet > total Assets
10208000
Annuals > 3 > balance Sheet > payables
875000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7353000
Annuals > 3 > balance Sheet > equity
2855000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-9827000
Annuals > 3 > cash Flow > depreciation
389000
Annuals > 3 > cash Flow > change In Working Capital
-96000
Annuals > 3 > cash Flow > cash From Operations
-6794000
Annuals > 3 > cash Flow > capital Expenditures
1640000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
10772000
Annuals > 3 > cash Flow > net Change In Cash
2338000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.7582058012966886
Annuals > 3 > ratios > PB
22.42614828021016
Annuals > 3 > ratios > ROE
-344.2031523642732
Annuals > 3 > ratios > ROA
-96.26763322884013
Annuals > 3 > ratios > FCF
-8434000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.012369172216936
Annuals > 3 > health Score
12
Valuation > metrics > PE
-0.12810722467652033
Valuation > metrics > PB
12.528108235294118
Valuation > final Score
20
Valuation > verdict
317.6% Overvalued
Profitability > metrics > ROE
-32.48868778280543
Profitability > metrics > ROA
-14.087112506306406
Profitability > metrics > Net Margin
-0.27715892798058894
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.549191984486102
Risk > metrics > Interest Coverage
-0.6013071895424836
Risk > final Score
4
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.118794835007174
Liquidity > metrics > Quick Ratio
3.84648493543759
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
0
Prev Risks > 0
27
Prev Risks > 1
18
Prev Risks > 2
-75
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:29:13.664Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.14
Earnings History > 0 > eps Estimate
-0.115
Earnings History > 0 > eps Difference
-0.025
Earnings History > 0 > surprise Percent
-21.7391
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.24
Earnings History > 1 > eps Estimate
-0.1075
Earnings History > 1 > eps Difference
-0.1325
Earnings History > 1 > surprise Percent
-123.2558
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
-0.12
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-8.3333
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.1233
Earnings History > 3 > eps Difference
-0.0467
Earnings History > 3 > surprise Percent
-37.8751
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.16
Earnings History > 4 > eps Estimate
-0.05
Earnings History > 4 > eps Difference
-0.11
Earnings History > 4 > surprise Percent
-220
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Weekly: Can BHST expand its profit margins - 2025 Biggest Moves & High Accuracy Swing Trade Signals baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BioHarvest Sciences Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.14
EPS Estimate
-0.115
EPS Difference
-0.025
Surprise Percent
-21.7391%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.